SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending amid discussions of a potential currency reset and global economic uncertainty, driving a surge towards record highs. Community members are actively debating whether this rally signals an overbought condition or the beginning of a larger, sustained move, with some pointing to central bank activity and international tensions as potential catalysts. Others suggest it's a flight to safety amid concerns about the dollar's weakening position and broader market instability.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as traders debate its correlation to Bitcoin's price movements and potential S&P 500 inclusion, with some expressing frustration over its recent performance. Community members are actively discussing dip-buying opportunities and potential catalysts, including speculation around a Joe Rogan podcast appearance by Michael Saylor. Concerns linger about dilution and the stock's ability to capture Bitcoin's upside, while others remain bullish, citing long-term potential and accumulation phases.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing (RGTI) is trending amid volatility and a significant price correction after a substantial run-up, with community discussions focused on whether this marks the end of the quantum computing hype cycle or a buying opportunity. Concerns about high valuations, potential stock dilution, and insiders selling shares are being weighed against the long-term potential of quantum computing and recent endorsements from major financial institutions. Some traders are betting against the stock, while others remain bullish, anticipating a rebound.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors digest news of HR downsizing amidst a broader tech streamlining trend and potential implications of a Trump tariff plan. The community is actively debating whether Amazon's AI and AWS initiatives can fuel a bullish recovery, or if the company faces further correction due to disappointing earnings and increased competition. Mixed sentiment and upcoming earnings are key focal points.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

ONDS is trending due to volatility following a recent equity offering, sparking debate among traders about whether it represents smart growth funding or potential shareholder dilution. Community members are actively discussing the company's drone and AI technology, its potential impact on the defense sector, and the possibility of a significant rebound or further downside.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending as investors discuss its potential transition into an AI infrastructure play, fueled by the launch of Black Pearl Phase 1 and rumors of a hyperscaler deal. Community members are weighing the risks and opportunities, with some suggesting profit-taking while others advocate holding for long-term gains in the data center sector. The stock's volatility and sensitivity to broader market trends are also key talking points.

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

Bitfarms Ltd.

BITF is trending as investors digest news of a proposed convertible senior note offering, leading to volatility and a price pullback. The community is actively debating the implications of the offering, with some viewing it as a strategic move for long-term growth into AI and data centers, while others express concerns about potential dilution. Overall sentiment is mixed as traders assess the news within the context of the broader crypto mining sector and Bitcoin's price movements.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

PRAX is trending due to positive Phase 3 trial results for its essential tremor treatment, leading to significant price movement and analyst upgrades. The community is buzzing about the potential for a large public offering and debating whether to go long or short, with some citing high institutional ownership as a bullish signal. Traders are closely watching for potential dilution impacts and debating price targets.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is trending as the community debates its valuation and recent partnerships, including a deal with Swiss Quantum Technology SA. While some express concerns about insider selling and question the company's revenue, others highlight its technology advancements and potential for future growth in the quantum computing sector. The stock's high volatility and the broader discussion around quantum computing's commercial viability are also fueling the conversation.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending due to community discussion around the recent FDA approval of Tonmya for fibromyalgia, with some investors viewing the subsequent stock drop as a buying opportunity while others express concerns about potential dilution. The conversation highlights differing opinions on the drug's advantages and the company's future prospects, particularly regarding execution and market reception. Traders are actively weighing bullish arguments against bearish signals, such as lack of PR and insider buying.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Legend Biotech Corp. (LEGN) is reportedly considering a second listing outside of the US.According to a Bloomberg <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-05/legend-biotech-is-said-to-explore-second-listing-outside-of-us">report</a> on Friday, which cited unnamed people familiar with the matter, the New Jersey-headquartered company has discussed a second listing option with potential advisers. The company may list in Hong Kong, Singapore, or London, the report stated, while noting that a second listing could help boost the company's valuation, particularly if in Hong Kong.Hong Kong is currently emerging as a hub for biotech company listing, and the city’s Hang Seng Biotech Index has surged more than 100% this year, the report added.However, the company is only considering a second listing and may eventually decide against it, sources told Bloomberg.<a href="https://stocktwits.com/symbol/LEGN">LEGN shares</a> traded 3% higher at the time of writing. On Stocktwits, retail sentiment around LEGN stayed within ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.In August, Legend reported second-quarter (Q2) adjusted net income of $10.1 million, compared to an adjusted net loss of $2.5 million for the three months ended June 30, 2024, and total revenue of $255.1 million. The company ended June with cash and cash equivalents, as well as time deposits, totaling $1 billion.Legend, founded in 2014, is centered in the U.S. despite having roots in China and employs over 2,800 people. It's known for Carvykti, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets in collaboration with Johnson &amp; Johnson.LEGN stock is up 11% this year but down approximately 33% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/immunome-stock-rises-after-craig-hellum-initiates-coverage-with-26-dollar-price-target/chwIWHxRdqE">Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Legend Biotech Corporation logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Legend Biotech Considering Second Listing Outside US: Report

According to a Bloomberg report, the New Jersey-based company has discussed the option with potential advisers.

Equity

BlackRock Institutional Trust Company N.A. - iShares MSCI All Country Asia ex Japan ETF

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$92.85
Prev Close	$92.32
Open	$93.29
Dividend Yield	N/A
50-Day Moving Average	$88.90
Beta	N/A
Avg. Volume	457,157.05
PE Ratio	N/A

52-Week High	$94.15
52-Week Low	$64.33
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

AAXJ
iShares MSCI All Country Asia ex-Japan ETF

Feed

News

Sentiment

Fundamentals

Info

Latest AAXJ News

AAXJiShares MSCI All Country Asia ex-Japan ETF